These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Late clinical failure associated with cytochrome b codon 268 mutation during treatment of falciparum malaria with atovaquone-proguanil in traveller returning from Congo. Massamba L; Madamet M; Benoit N; Chevalier A; Fonta I; Mondain V; Jeandel PY; Amalvict R; Delaunay P; Mosnier J; Marty P; Pomares C; Pradines B Malar J; 2020 Jan; 19(1):37. PubMed ID: 31964401 [TBL] [Abstract][Full Text] [Related]
4. Open randomized study of artesunate-amodiaquine vs. chloroquine-pyrimethamine-sulfadoxine for the treatment of uncomplicated Plasmodium falciparum malaria in Nigerian children. Sowunmi A; Fehintola FA; Adedeji AA; Gbotosho GO; Tambo E; Fateye BA; Happi TC; Oduola AM Trop Med Int Health; 2005 Nov; 10(11):1161-70. PubMed ID: 16262741 [TBL] [Abstract][Full Text] [Related]
5. Treatment of uncomplicated multidrug-resistant falciparum malaria with artesunate-atovaquone-proguanil. van Vugt M; Leonardi E; Phaipun L; Slight T; Thway KL; McGready R; Brockman A; Villegas L; Looareesuwan S; White NJ; Nosten F Clin Infect Dis; 2002 Dec; 35(12):1498-504. PubMed ID: 12471569 [TBL] [Abstract][Full Text] [Related]
6. Artemisinin derivatives and malaria: useful, in combination with other antimalarials. Prescrire Int; 2008 Aug; 17(96):162-8. PubMed ID: 19492494 [TBL] [Abstract][Full Text] [Related]
7. In vitro atovaquone/proguanil susceptibility and characterization of the cytochrome b gene of Plasmodium falciparum from different endemic regions of Thailand. Khositnithikul R; Tan-Ariya P; Mungthin M Malar J; 2008 Jan; 7():23. PubMed ID: 18226262 [TBL] [Abstract][Full Text] [Related]
8. Atovaquone and proguanil versus amodiaquine for the treatment of Plasmodium falciparum malaria in African infants and young children. Borrmann S; Faucher JF; Bagaphou T; Missinou MA; Binder RK; Pabisch S; Rezbach P; Matsiegui PB; Lell B; Miller G; Kremsner PG Clin Infect Dis; 2003 Dec; 37(11):1441-7. PubMed ID: 14614665 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of non-artemisinin- and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon. Whegang SY; Tahar R; Foumane VN; Soula G; Gwét H; Thalabard JC; Basco LK Malar J; 2010 Feb; 9():56. PubMed ID: 20170477 [TBL] [Abstract][Full Text] [Related]
10. Artemisinin-based combination therapy (ACT) versus atovaquone-proguanil: do not choose between but, rather, combine them. Schwartz E; Lachish T Evid Based Med; 2016 Apr; 21(2):64. PubMed ID: 26759150 [No Abstract] [Full Text] [Related]
11. Atovaquone and proguanil for Plasmodium falciparum malaria. Radloff PD; Philipps J; Nkeyi M; Hutchinson D; Kremsner PG Lancet; 1996 Jun; 347(9014):1511-4. PubMed ID: 8684102 [TBL] [Abstract][Full Text] [Related]
12. [Tolerance and efficacy of atovaquone-proguanil for the treatment of paediatric imported Plasmodium falciparum malaria in France: clinical practice in a university hospital in Paris]. Blondé R; Naudin J; Bigirimana Z; Holvoet L; Fenneteau O; Vitoux C; Bourdon O; Angoulvant F; Lorrot M; D'Ortenzio E; Bourrillon A; Le Bras J; Matheron S; Faye A Arch Pediatr; 2008 Mar; 15(3):245-52. PubMed ID: 18321692 [TBL] [Abstract][Full Text] [Related]
13. Mutations in the Plasmodium falciparum cytochrome b gene are associated with delayed parasite recrudescence in malaria patients treated with atovaquone-proguanil. Sutherland CJ; Laundy M; Price N; Burke M; Fivelman QL; Pasvol G; Klein JL; Chiodini PL Malar J; 2008 Nov; 7():240. PubMed ID: 19021900 [TBL] [Abstract][Full Text] [Related]
14. Clinical atovaquone-proguanil resistance of Plasmodium falciparum associated with cytochrome b codon 268 mutations. Musset L; Bouchaud O; Matheron S; Massias L; Le Bras J Microbes Infect; 2006 Sep; 8(11):2599-604. PubMed ID: 16962361 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania. Mårtensson A; Strömberg J; Sisowath C; Msellem MI; Gil JP; Montgomery SM; Olliaro P; Ali AS; Björkman A Clin Infect Dis; 2005 Oct; 41(8):1079-86. PubMed ID: 16163624 [TBL] [Abstract][Full Text] [Related]
17. Apparent absence of atovaquone/proguanil resistance in 477 Plasmodium falciparum isolates from untreated French travellers. Musset L; Pradines B; Parzy D; Durand R; Bigot P; Le Bras J J Antimicrob Chemother; 2006 Jan; 57(1):110-5. PubMed ID: 16319183 [TBL] [Abstract][Full Text] [Related]
19. Atovaquone-proguanil for recrudescent Plasmodium falciparum in Vietnam. Giao PT; De Vries PJ; Hung LQ; Binh TQ; Nam NV; Kager PA Ann Trop Med Parasitol; 2003 Sep; 97(6):575-80. PubMed ID: 14511555 [TBL] [Abstract][Full Text] [Related]
20. Atovaquone and proguanil hydrochloride for prophylaxis of malaria. Shanks GD; Kremsner PG; Sukwa TY; van der Berg JD; Shapiro TA; Scott TR; Chulay JD; J Travel Med; 1999 May; 6 Suppl 1():S21-7. PubMed ID: 23573549 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]